Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia

Annals of Pharmacotherapy

Volumn 39, Issue 5, 2005, Pages 939-943

  Paulós, Claudio P ^a,b   Akesson Nygren, Carin E ^c   Celedón, Consuelo ^d   Cárcamo, Carina A ^d  

^a UNIVERSITY OF CHILE   (Chile)

^b Farmacias Ahumada SA   (Chile)

^c UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^d Farmacias Ahumada SA ^*  (Chile)

Author keywords

Community pharmacy; Drug related problems; Dyslipidemia; Pharmaceutical care

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ATORVASTATIN; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INTERVIEW; LIFESTYLE; MALE; OUTPATIENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CHILE; COMMUNITY PHARMACY SERVICES; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACEUTICAL PREPARATIONS; PYRROLES; QUALITY OF LIFE;

EID: 17644366473     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E347     Document Type: Review

References (21)

1. Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
2. Cipolle RJ, Morley PC, Strand LM. Pharmaceutical care practice. New York: McGraw-Hill, 1998.
3. Rovers J, Currie J, Hagel H, McDonough R, Sobotka J. A practical guide to pharmaceutical care. 2nd ed. Washington, DC: APhA Publications, 1998.
4. Faus M, Martínez F. La atención farmacéutica en farmacia comunitaria: evolución de conceptos, necesidades de formación, modalidades y estrategias para su puesta en marcha. Pharm Care Esp 1999;1:52-61.
5. Departamento de Epidemiología. Los objetivos sanitarios para la década 2000-2010. Santiago, Chile: Ministerio de Salud de Chile (MINSAL), 2002.
6. Departamento de Programas de Salud de las personas. Prioridades en problemas de salud relacionados con la alimentación y nutrición. Santiago, Chile: Ministerio de Salud de Chile (MINSAL), 1995.
7. Tsuyuki RT, Johnson JA, Teo KK, Ackman ML, Biggs RS, Cave A, et al. Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk. Ann Pharmacother 1999;33:910-9. DOI 10.1345/aph.18380.
8. Berrios X, Jadue L, Pietrotic M. Perfil lipídico en la población adulta de la región metropolitana. Rev Med Chile 1992;120:331-3.
9. Arteaga E, Pollack F. Dislipidemias en la parte clínica. Santiago, Chile: Internacional Lipid Information Bureau, Comité Chileno, 2000.
10. Dadidoff P. El colesterol y los triglicéridos en la aterosclerosis: consideraciones epidemiológicas y fisiopatoló gicas. Rev Med Chile 1991;119:1050-8.
11. Carmena R, Ordovás J. Hiperlipemias: clínica y tratamiento. Barcelona: Doyma, 1999.
12. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000;40:157-65.
13. Obesity: preventing and managing the global epidemic. WHO Technical Report Series, No. 894. Geneva: World Health Organization, 1998.
14. Badia X, Salamero M, Alonso J. Medida de la salud: guía de escalas de medición en español. Barcelona: Edimac, 1995.
15. Prieto J. El perfil de seguridad de las estatinas. Rev Med Chile 2001;129:1237-40.
16. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel of detection, evaluation, and treatment of high blood cholesterol in adults (Adults Treatment Panel II). JAMA 1993;269:3015-23.
17. Pauley TR, Magee MJ, Cury JD. Pharmacist-managed, physician-directed asthma management program reduces emergency department visits. Ann Pharmacother 1995;29:5-9.
18. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc 1996;NS36:443-51.
19. Van Veldhuizen-Scott MK, Widmer LB, Stacey SA, Popovich NG. Developing and implementing a pharmaceutical care model in an ambulatory care setting for patients with diabetes. Diabetes Educ 1995;21:117-23.
20. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997;31:713-9.
21. Ibrahim OI, Catania PN, Mergener MA, Supernaw RB. Outcome of cholesterol screening in a community pharmacy. DICP 1990;24:817-21.